fr

CARMAT announces the first commercial implants of its Aeson® artificial heart outside the European Union

CARMAT advances the internationalization of the PIVOTAL study and obtains the approval to perform implants in Denmark

Download

2017 Annual Results

Download

2018 Financial Calendar

Download

CARMAT announces the success of its capital increase for an amount of €52.9 million after full exercise of the increase option

Download

CARMAT launches a capital increase for an initial amount of €46 million

Download

First implantation in the Czech Republic within the framework of the PIVOTAL study international expansion

Download

CARMAT signs a partnership agreement with AddUp

Download

CARMAT accelerates the internationalization of the PIVOTAL study and obtains the approval to perform implants in the Czech Republic

Download
Top of page